cobas® Liat® Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.
Respiratory
Influenza A/B
Influenza A/B + RSV
Strep A
SARS-CoV-2 + Influenza A/B***
Antimicrobial stewardship
Cdiff**
cobas® Liat® Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.
Infectious Diseases
HIV-1**§
HBV**
HCV**
HCV GT**
Transplant
CMV**
Genomics and oncology
EGFR v2
BRAF
KRAS
Factor II/V
PIK3CA†
BRAF/NRAS‡
KRAS v2‡
Sexual Health
HPV
CT/NG
HSV 1/2
Antimicrobial stewardship
MRSA/SA
Cdiff
MG Resistance**
GC Resistance**
User defined functionality (UDF)
cobas® 4800 System Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.
Donor Screening
MPX
DPX
HEV**
CHIKV/DENV**
Zika
Babesia
Malaria*
Infectious Diseases
HIV-1§
HBV
HCV
HIV-1/2 Qual
HIV-1/2/VZV†##
Sexual Health
HPV∥
CT/NG
TV/MG
PivNG†##
Respiratory
Influenza A/B + RSV†##
MTB**
MAI**
SARS-CoV-2***
SARS-CoV-2 + Influenza A/B***
Influenza A/B + RSV*#
MPLX Respiratory*
Parainfluenza 1-4*
AMER*
Transplant
CMV
EBV
BKV
ADV Quant**#
HSV-1/2/VZV**#
Antimicrobial stewardship
MTB-RIF/INH**
Cdiff†##
MG Resistance*
GC Resistance*
cobas omni Utility Channel for third-party tests and LDTs
cobas® 6800/8800 System Assays are available in countries accepting CE-mark and FDA approval unless indicated otherwise.
Gastro Parasite Panel
GiardiaCE
Dientamoeba fragilisCE
Cryptosporidium sppCE
BlastocystisCE
Entamoeba histoliticaCE
Gastro Virus Panel
Novovirus GG1CE
Novovirus GG2CE
SapovirusCE
RotavirusCE
AdenovirusCE
AstrovirusCE
Gastro Bacteria Panel
AeromonasCE
Yersinia enterocoliticaCE
CampylobacterCE
Shigella/EIECCE
SalmonellaCE
Plesiomonas
Emerging Pathogens Panel
Zika VirusCE
Respiratory Influenza Panel
Influenza ACE
Influenza BCE
Influenza A H1 (H1N1)CE
Influenza A H3
Influenza A H5
Influenza A H7 (H7N9)
Influenza A H9
Respiratory Virus Panel
RSVCE
ParaInfluenza 1CE
ParaInfluenza 2CE
ParaInfluenza 3CE
ParaInfluenza 4CE
EnterovirusCE
BocavirusCE
ParechovirusCE
MetapneumovirusCE
AdenovirusCE
PicornavirusCE
Rhinovirus
Respiratory Coronavirus Panel
Sarbecovirus SARS-CoV-2CE
SARS-CoV-2 (COVID 19) N-gene
SARS-CoV-2 (COVID 19) E-gene
SARS-CoV-2 (COVID 19) RdRP-gene
MERS Coronavirus UpE
MERS Coronavirus Orf1a
Coronavirus HKU1
Coronavirus OC43
Coronavirus 229E
Coronavirus NL63
panCoronavirus
Respiratory Bacteria Panel
Bordetella pertussis
Bordetella parapertussis
Respiratory Atypical pneumonia Panel
Pneumocystis jirovecii
Mycoplasma pneumoniae
Chlamydophila psittaci
Chlamydia pneumoniae
Legionella pneumophila
Legionella spp/pn
Carbapenemase Panel
KPCCE
OXA-23CE
GESCE
VIMCE
NDMCE
OXA-48CE
IMPCE
EHEC Panel
STX1-EHEC
STX2-EHEC
EAE-EHEC
New Born Panel
TREC
KREC
Non-Culturable Panel
T. whipplei
Filovirus Panel
Ebola Zaire
Tropical Panel
Zika
Dengue
Chikungunya
Plasmodium genus
Bacterial Meningitis Panel
Escherichia coli uidA
Listeria monocytogenes
Streptococcus pneumoniae
Neisseria meningitidis
Streptococcus agalactiae
Haemophilus influenzae
Resistance Panel
MCR-1
| * | In development |
| ** | Not available in the US |
| *** | Emergency Use Authorization (EUA) & CE-IVD |
| † | Research use only (RUO); not for use in diagnostic procedures |
| ‡ | Life Science Research (LSR); not for use in diagnostic procedures |
| # | cobas omni Utility Channel CE-IVD |
| ## | cobas omni Utility Channel Primer/Probe Set |
| § | HIV-1 can be run with plasma on the cobas® Plasma Separation Card for viral load quantification and with Dried Blood Spots as a qualitative test |
| ∥ | Self-sampling in development |
| CE | Available in countries accepting CE-mark |
Assays are not available in all markets; check with your local Roche affiliate about availability and registration status in your area.
Our assay portfolio spans across a wide range of diseases. Explore our key diagnostic fields below.